Infectious Diseases News and Research

RSS

Scientists leverage machine learning and AI to guide vaccine development

From tackling homework challenges to drafting emails, people are discovering a vast array of applications for natural language processing tools like generative artificial intelligence (AI) engines.

11 Aug 2023

COVID-19 mRNA vaccine or booster during pregnancy benefits mother and baby, study finds

Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to findings recently published in Vaccine.

11 Aug 2023

Discontinuation of pandemic-related food assistance benefits led to substantial increase in food insufficiency in the U.S.

The recent discontinuation of pandemic-related food assistance benefits, known as the Supplemental Food Assistance Program (SNAP) Emergency Allotments, led to a substantial increase in food insufficiency in the United States, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania.

11 Aug 2023

COVID-19 lockdown may have led to waning immunity to gastrointestinal viruses

Following the first stay-at-home orders issued in the U.S. to curb the spread of COVID-19, gastrointestinal viruses such as norovirus, rotavirus and adenovirus all but disappeared from California communities, and remained at very low levels for nearly 2 years.

11 Aug 2023

A third dose boosted cross-protection against SARS-CoV-2 viral variants, finds study

Transplant recipients must take life-long immunosuppressive medications to prevent rejection, but these drugs can compromise the effectiveness of vaccines.

11 Aug 2023

Good Trials Prism: A new partnership to enhance clinical research in low resource settings

Four major clinical trial networks based in low resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative to enhance clinical research in low resource settings.

10 Aug 2023

Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

Researchers review existing data on the molecular basis of senescence and neurodegeneration in age-related brain diseases.

10 Aug 2023

Hepatitis C treatment initiation found to be low among Medicaid recipients

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University's Ithaca campus.

8 Aug 2023

SLU research finds link between anxiety disorders, benzodiazepine exposure and dementia in seniors

Research from Saint Louis University School of Medicine finds that among patients 65 and older, a diagnosis of anxiety was significantly associated with an increased risk of dementia diagnosis, and benzodiazepine exposure was associated with a 28% increased risk of dementia.

7 Aug 2023

Phage therapy shows promise in treating tough Pseudomonas aeruginosa infections

A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The Hebrew University of Jerusalem, using phage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections, has shown promising results with an 86.6% success rate.

7 Aug 2023

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.

7 Aug 2023

Insilico Medicine's new AI tool shows promise in predicting clinical trial outcomes

Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has demonstrated that it can predict the outcome of Phase II to Phase III clinical trial success using its proprietary transformer-based AI clinical trial prediction tool called inClinico with a high degree of accuracy.

3 Aug 2023

NIH awards $18 million to develop novel chikungunya vaccine

The Access to Advanced Health Institute (AAHI) announced today that it has received an $18 million award from the National Institutes of Health (NIH) to develop a temperature stable, single-dose vaccine candidate for the chikungunya virus.

3 Aug 2023

Child-friendly HIV drug could improve treatment outcomes

Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).

2 Aug 2023

Insilico Medicine uses AI to discover novel SIK2 inhibitors

Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple generative AI models and AlphaFold structures for drug discovery.

2 Aug 2023

Novel molecules inspired by the immune system inactivate several viruses

Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs. But what if a new generation of antivirals ignores the fast-mutating proteins on the surface of viruses and instead disrupts their protective layers?

2 Aug 2023

Infectious Diseases News and Research

Scientists leverage machine learning and AI to guide vaccine development

COVID-19 mRNA vaccine or booster during pregnancy benefits mother and baby, study finds

Discontinuation of pandemic-related food assistance benefits led to substantial increase in food insufficiency in the U.S.

COVID-19 lockdown may have led to waning immunity to gastrointestinal viruses

A third dose boosted cross-protection against SARS-CoV-2 viral variants, finds study

Good Trials Prism: A new partnership to enhance clinical research in low resource settings

Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

Hepatitis C treatment initiation found to be low among Medicaid recipients

SLU research finds link between anxiety disorders, benzodiazepine exposure and dementia in seniors

Phage therapy shows promise in treating tough Pseudomonas aeruginosa infections

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

Insilico Medicine's new AI tool shows promise in predicting clinical trial outcomes

NIH awards $18 million to develop novel chikungunya vaccine

Child-friendly HIV drug could improve treatment outcomes

Insilico Medicine uses AI to discover novel SIK2 inhibitors

Novel molecules inspired by the immune system inactivate several viruses

Peptoid antiviral therapy inactivates three viruses in lab tests

Study assesses the value of predictive biomarkers for early-stage COVID-19 infection

Three doses of mRNA vaccine provide good protection for vulnerable people

Research reveals surprising genetic overlap between neurological and psychiatric disorders

Industry Focus: Infectious Diseases eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News